We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
10 Year Est. Return
AUM
$1.57B
AUM Growth
+$203M
Cap. Flow
+$147M
Cap. Flow %
9.31%
Top 10 Hldgs %
84.02%
Holding
361
New
29
Increased
183
Reduced
103
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 2.52%
2 Financials 2.31%
3 Energy 2.1%
4 Industrials 1.95%
5 Consumer Staples 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIDI icon
1
Vident International Equity Strategy
VIDI
$433M
$717M 45.53%
27,986,115
+844,685
+3% +$21.3M
IAU icon
2
iShares Gold Trust
IAU
$62.9B
$255M 16.19%
9,900,422
+400,179
+4% +$10M
VUSE icon
3
Vident US Equity Strategy ETF
VUSE
$675M
$164M 10.42%
6,186,712
+4,302,497
+228% +$111M
ACWX icon
4
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$75.7M 4.8%
1,575,414
+54,407
+4% +$2.59M
EEMV icon
5
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
$45.6M 2.9%
759,475
+16,920
+2% +$1M
ACWI icon
6
iShares MSCI ACWI ETF
ACWI
$32.9B
$34.7M 2.21%
576,603
-62,204
-10% -$3.69M
XOM icon
7
ExxonMobil
XOM
$644B
$11.3M 0.72%
112,058
-2,554
-2% -$258K
HCA icon
8
HCA Healthcare
HCA
$87.2B
$7.74M 0.49%
137,330
CFR icon
9
Cullen/Frost Bankers
CFR
$10.3B
$6.38M 0.41%
80,387
+296
+0.4% +$22.8K
PG icon
10
Procter & Gamble
PG
$336B
$5.58M 0.35%
71,073
-730
-1% -$58.9K
AAPL icon
11
Apple
AAPL
$4.54T
$4.93M 0.31%
212,040
+8,732
+4% +$186K
LPNT
12
DELISTED
LifePoint Health, Inc.
LPNT
$4.79M 0.3%
77,191
LLY icon
13
Eli Lilly
LLY
$1.02T
$4.74M 0.3%
76,230
+59
+0.1% +$3.52K
EFA icon
14
iShares MSCI EAFE ETF
EFA
$78B
$4.29M 0.27%
62,733
+6,569
+12% +$450K
KO icon
15
Coca-Cola
KO
$377B
$4.21M 0.27%
99,488
+963
+1% +$39.1K
CVX icon
16
Chevron
CVX
$392B
$4.21M 0.27%
32,220
+1,206
+4% +$150K
VZ icon
17
Verizon
VZ
$195B
$3.97M 0.25%
81,124
+5,374
+7% +$260K
EEM icon
18
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$3.23M 0.2%
74,606
+49,045
+192% +$2.08M
DOV icon
19
Dover
DOV
$27.6B
$3.22M 0.2%
43,808
+1
+0% +$70
T icon
20
AT&T
T
$159B
$3.17M 0.2%
118,808
+6,336
+6% +$170K
IVV icon
21
iShares Core S&P 500 ETF
IVV
$878B
$3.09M 0.2%
15,689
-1,277
-8% -$244K
IBM icon
22
IBM
IBM
$211B
$3.05M 0.19%
17,583
+303
+2% +$54.5K
MDLZ icon
23
Mondelez International
MDLZ
$79.5B
$2.9M 0.18%
77,195
+383
+0.5% +$14K
PFE icon
24
Pfizer
PFE
$143B
$2.87M 0.18%
101,750
+9,839
+11% +$280K
JNJ icon
25
Johnson & Johnson
JNJ
$618B
$2.62M 0.17%
25,071
-49
-0.2% -$4.95K

Similar funds

Ronald Blue & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Ronald Blue & Co held 361 positions worth $1.57B, up 15% from $1.37B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Ronald Blue & Co deployed $147M of net new capital in Q2 2014, opening 29 new positions and adding to 183 existing holdings. Its largest new stake was Alphabet (Google) Class C: 61,889 shares worth $1.79M.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, down from 2.7% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was iShares MSCI ACWI ETF, an estimated $3.69M trimmed.

  • Ronald Blue & Co's largest Q2 2014 buy was Alphabet (Google) Class C: 61,889 shares worth $1.79M.
  • Ronald Blue & Co added most to Vident US Equity Strategy ETF in Q2 2014, an estimated $111M increase.
  • Ronald Blue & Co's biggest Q2 2014 reduction was iShares MSCI ACWI ETF, cutting an estimated $3.69M.
  • Ronald Blue & Co fully exited Vale in Q2 2014, selling an estimated $741K.
  • Ronald Blue & Co's ten largest holdings make up 84% of its $1.57B portfolio in Q2 2014.
  • Ronald Blue & Co opened 29 new positions and closed 20 in Q2 2014.
  • Ronald Blue & Co's portfolio value rose 15% quarter-over-quarter to $1.57B.

Based on Ronald Blue & Co's 13F filing for Q2 2014, filed 6 Aug 2014.